Sunday November 8, 2009 11:56 AM ET
SmartMoney
Net Asset Value: 
116.22
1-Day Return: 
0.33 (0.28%)
YTD Return
as of 11/6/09: 
Up 14.63%
VGHCX 
(Vanguard Health Care;Inv)
Classification: GL Health/Biotechnology     Objective: GL Health/Biotech
Open to New Investors: Yes
Lipper Rating
Total Return
Consistent Return
Preservation
Tax Efficiency
Expense
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
NAV Chart | Growth of $10,000
Fund Chart
Total Returns (As of 11/06/2009)
 YTD1Yr3Yr5Yr10Yr
Fund 14.63 24.06 -0.58 5.50 8.73
Classification 14.49 18.09 -2.53 2.74 5.11
Index (S&P 500) 20.90 21.30 -6.10 0.30 -0.70
% Rank in Class (1-best,100=worst)531126117
Fund Stats
Investment Objective:GL Health/Biotech
Net Assets ($Mil)10,976.20
Inception Date:5/23/84
Manager Name, TenureOwens/Hynes, 1984 / 2008
Expense Ratio: 0.29%
Sales Charge:
Load Type:
 
No Load
0.00%
0.00%
Top 10 Holdings (As of 6/30/09)
Company NameSymbol% Net Assets
Schering Plough Corp SGP 7.49
Forest Laboratories Inc FRX 4.24
Eli Lilly And Co LLY 3.86
Astrazeneca Plc AZNCF 3.72
Abbott Laboratories ABT 3.48
Merck MRK 3.46
Wyeth WYE 3.26
Roche Holding Ag RHHVF 3.03
Mckesson Corp MCK 2.83
Astellas Pharma Inc NA 2.82
% of Total Holdings 38.19
Advertisements
View Overview for: